Insulet Corp. Stock Underperforms Monday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares fell 1.85% to $145.42 on Monday, underperforming compared to competitors like Eli Lilly and DexCom during a mixed market session. The stock remains significantly below its 52-week high of $354.88. Trading volume matched its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) slipped 1.85% to $145.42 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.26% to 53,417.16 and the S&P 500 Index falling 0.28% to 7,652.86.
Insulet Corp. closed 59.02% short of its 52-week high of $354.88, which the company achieved on November 20th.
The stock underperformed when compared to some of its competitors Monday, as Eli Lilly & Co. (LLY) fell 0.67% to $1,246.93, DexCom Inc. (DXCM) fell 1.39% to $91.06, and Johnson & Johnson (JNJ) rose 1.04% to $273.04.
Trading volume (1.6 M) eclipsed its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-24-26 1716ET